GYNTECH: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GYNTECH
Largest movements
- Cash -€9,037
down €9,037 (-35.4%), from €25,558 to €16,521
mainly Other debts (-€6,168) and Accrued charges and deferred income (-€3,250)
- Receivables within one year -€629
down €629 (-21.4%), from €2,937 to €2,309
of which Other amounts receivable: -€326
- Other debts -€6,168
down €6,168 (-11.5%), from €53,570 to €47,402
- Profit (loss) carried forward +€3,339
up €3,339 (+6.4%), from -€52,408 to -€49,069
- Accrued charges and deferred income -€3,250
down €3,250 (-100.0%), from €3,250 to €0
- Trade debts -€2,212
down €2,212 (-75.5%), from €2,930 to €718
- Tax, wage and social debts -€1,296
down €1,296 (-32.3%), from €4,010 to €2,715
- Gross operating margin -€2,746
down €2,746 (-33.1%), from €8,300 to €5,554
- Other operating charges -€547
down €547 (-51.3%), from €1,067 to €520
- Financial charges +€105
up €105 (+55.9%), from €188 to €293
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,944 | €20,358 | -€9,586 | -32.0% |
| Current assets | 29/58 | €29,944 | €20,358 | -€9,586 | -32.0% |
| Amounts receivable within one year | 40/41 | €2,937 | €2,309 | -€629 | -21.4% |
| Trade receivables | 40 | €1,120 | €817 | -€303 | -27.0% |
| Other amounts receivable | 41 | €1,817 | €1,492 | -€326 | -17.9% |
| Cash at bank and in hand | 54/58 | €25,558 | €16,521 | -€9,037 | -35.4% |
| Deferred charges and accrued income | 490/1 | €1,449 | €1,528 | +€79 | +5.5% |
| Total equity and liabilities | 10/49 | €29,944 | €20,358 | -€9,586 | -32.0% |
| Equity | 10/15 | -€33,816 | -€30,477 | +€3,339 | +9.9% |
| Contributions | 10/11 | €18,592 | €18,592 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€52,408 | -€49,069 | +€3,339 | +6.4% |
| Amounts payable | 17/49 | €63,760 | €50,835 | -€12,925 | -20.3% |
| Amounts payable within one year | 42/48 | €60,510 | €50,835 | -€9,675 | -16.0% |
| Trade debts | 44 | €2,930 | €718 | -€2,212 | -75.5% |
| Suppliers | 440/4 | €2,930 | €718 | -€2,212 | -75.5% |
| Taxes, remuneration and social security | 45 | €4,010 | €2,715 | -€1,296 | -32.3% |
| Taxes | 450/3 | €4,010 | €2,715 | -€1,296 | -32.3% |
| Other amounts payable | 47/48 | €53,570 | €47,402 | -€6,168 | -11.5% |
| Accrued charges and deferred income | 492/3 | €3,250 | €0 | -€3,250 | -100.0% |
| Other operating charges | 640/8 | €1,067 | €520 | -€547 | -51.3% |
| Gross operating margin | 9900 | €8,300 | €5,554 | -€2,746 | -33.1% |
| Operating profit (loss) | 9901 | €7,233 | €5,034 | -€2,199 | -30.4% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €188 | €293 | +€105 | +55.9% |
| Recurring financial charges | 65 | €188 | €293 | +€105 | +55.9% |
| Profit (loss) for the period before taxes | 9903 | €7,045 | €4,741 | -€2,304 | -32.7% |
| Income taxes | 67/77 | €1,338 | €1,402 | +€64 | +4.8% |
| Profit (loss) for the period | 9904 | €5,707 | €3,339 | -€2,368 | -41.5% |
| Profit (loss) for the period to be appropriated | 9905 | €5,707 | €3,339 | -€2,368 | -41.5% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 2 October 2026 via checked.be.